Drug data last refreshed 15h ago · AI intelligence enriched 2w ago
Fluothane (halothane) is an inhalational anesthetic liquid used for induction and maintenance of general anesthesia in surgical patients. It is a volatile halogenated hydrocarbon that depresses the central nervous system to produce unconsciousness and analgesia. Halothane has been a foundational agent in anesthesia since its approval in 1958, though its use has declined with the introduction of newer volatile anesthetics.
As a legacy anesthetic approaching loss of exclusivity, Fluothane operates in a mature, stable market with limited growth opportunities and correspondingly smaller dedicated commercial teams.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Fluothane offers minimal career growth prospects given its mature lifecycle stage, legacy status, and approaching loss of exclusivity. Roles on this product are primarily operational and maintenance-focused rather than strategic or growth-oriented, making it suitable primarily for professionals seeking stability in a niche anesthesia market rather than advancement.
Worked on FLUOTHANE at Thayer Medical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.